Genitourinary Radiology: Page 12

Clarity secures IND from FDA for radiotracer for prostate cancer

By AuntMinnie.com staff writers

Clarity Pharmaceuticals has secured investigational new drug approval (IND) from the U.S. Food and Drug Administration (FDA) to start a phase II clinical trial of a radiotracer for detecting cancer in asymptomatic patients.

June 5, 2022

Telix gets pass-through status for Illuccix

By AuntMinnie.com staff writers

Telix Pharmaceuticals has received transitional pass-through payment status from the U.S. Centers for Medicare and Medicaid Services for its Illuccix prostate-specific membrane antigen PET radiopharmaceutical.

May 30, 2022

FDA OKs new AI-based breast, prostate cancer tools from RadNet

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has given 510(k) clearance to artificial intelligence (AI)-based breast and prostate cancer detection tools from RadNet's subsidiaries DeepHealth and Quantib.

May 15, 2022

SNMMI updates guidelines on PSMA-PET imaging

By Will Morton

The Society for Nuclear Medicine and Molecular Imaging (SNMMI) is now considering all PSMA-PET radiotracers for detecting prostate cancer -- whether approved or not -- as equivalent, and it will refer to them as a class ("PSMA PET"), according to a recent update of the society's Appropriate Use Criteria.

May 12, 2022

Monrol to supply Telix with Lu-177 for renal cancer trial

By AuntMinnie.com staff writers

Eczacıbaşı-Monrol Nuclear Products will provide lutetium-177 (Lu-177) to Telix Pharmaceuticals Limited for a phase II clinical trial of its Starlite 2 renal cancer therapy medication TLX250.

May 10, 2022

MRI radiomics help predict prostate cancer metastases

By Kate Madden Yee

Radiomics features extracted from multiparametric MRI exams can help predict whether prostate cancer will metastasize, according to research presented at the International Society for Magnetic Resonance in Medicine meeting in London, U.K.

May 8, 2022

Radiomics, AI primed for bigger role in genitourinary applications

By Erik L. Ridley

Clinical use of radiomics and artificial intelligence (AI) in genitourinary applications has been limited to date, but that's likely to change in the future, according to a talk at the American Roentgen Ray Society meeting in New Orleans.

May 4, 2022

Fujitsu partners in Japan on AI for pancreatic cancer

By AuntMinnie.com staff writers

Fujitsu is partnering with a Japanese hospital on developing artificial intelligence (AI) technology for identifying pancreatic cancer on noncontrast CT exams.

April 24, 2022

Dialysis firm DaVita acquitted on labor collusion charges

By AuntMinnie.com staff writers

A federal jury in Colorado has acquitted kidney dialysis provider DaVita of conspiring with other firms -- including national radiology practice Radiology Partners -- of colluding to not hire each other's executives, according to an article in the Denver Post.

April 18, 2022

RSIP Vision launches new AI software for prostate MRI analysis

By AuntMinnie.com staff writers

Computer software and artificial intelligence (AI) company RSIP Vision has released an AI-based algorithm for prostate MRI analysis to support Prostate Imaging Reporting and Data System scoring.

April 10, 2022

Structural racism causes disparities in prostate MRI use

By Kate Madden Yee

Structural racism causes disparities in the use of MRI among Black and white men diagnosed with prostate cancer, with Black men less likely to get scans, according to research published March 3 in JAMA Oncology.

March 3, 2022

ECR: How can imaging screen for COVID damage to kidneys?

By Kate Madden Yee

With the COVID-19 pandemic now in at least a fourth wave, physicians have a better understanding of how the disease affects the body beyond the lungs -- including the kidneys, according to a session offered at the ECR 2022 Overture.

March 2, 2022

Previous Page

Page 12 of 93

Next Page